Back to Portfolio

Biognosys

A paradigm shifting proteomics platform - EXITED
 
Biognosys

BiognoSYS has developed a paradigm shifting proteomics platform. It provides patented tools to enable faster discovery of biomarkers that will play a pivotal role in tomorrow's more personalized medicine. Biomarkers will accelerate the drug development process, provide better diagnosis, and allow patient specific treatment schemes.


Homepage Twitter LinkedIn  

 

Biognosys in the News:

Another successful exit for Redalpine

Biognosys updates on some if its high-profile partnerships

 

Jobs at Biognosys

Another successful exit for Redalpine